AXS-05 consists of dextromethorphan, an NMDA receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor.
Your search for major depressive disorder returned 3 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
The Company will evaluate BNC210 in patients with SAD in the phase 2 PREVAIL trial.
Ensemble is an AI-powered digital mental health coach app designed to address the symptoms of MDD or GAD.
Latest News Your top articles for TuesdayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses